+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Small Molecule Drug"

From
From
From
From
Oncology Pharmaceuticals Market - Product Thumbnail Image

Oncology Pharmaceuticals Market

  • Report
  • October 2024
  • 181 Pages
  • Global
From
Antibody-Drug Conjugates: Technologies and Global Markets - Product Thumbnail Image

Antibody-Drug Conjugates: Technologies and Global Markets

  • Report
  • September 2024
  • 89 Pages
  • Global
From
From
Growth Indicators for Technology-enabled Drug Discovery - Product Thumbnail Image

Growth Indicators for Technology-enabled Drug Discovery

  • Report
  • June 2023
  • 77 Pages
  • Global
From
From
Protein Kinase C Theta Type - Pipeline Review, H2 2020 - Product Thumbnail Image

Protein Kinase C Theta Type - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 33 Pages
  • Global
From
Histone Lysine N Methyltransferase EZH2 - Pipeline Review, H1 2020 - Product Thumbnail Image

Histone Lysine N Methyltransferase EZH2 - Pipeline Review, H1 2020

  • Drug Pipelines
  • February 2020
  • 96 Pages
  • Global
From
From
From
Loading Indicator

The Small Molecule Drug market is a segment of the Pharmaceuticals industry that focuses on the development and production of drugs composed of small molecules. These drugs are typically used to treat a wide range of diseases, including cancer, diabetes, and cardiovascular diseases. Small molecule drugs are typically taken orally, and are designed to target specific areas of the body. The Small Molecule Drug market is highly competitive, with many companies vying for market share. Companies in the market include Pfizer, Merck, Novartis, GlaxoSmithKline, AstraZeneca, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of small molecule drugs, as well as the marketing and distribution of these drugs. Show Less Read more